Pfizer's McKinnell Cancels National Press Club Speech
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec was expected to discuss health care reform, and was likely to have been asked about cardiovascular safety of Celebrex and Bextra. McKinnell canceled the speech due to the flu, which he caught in Asia while assessing Pfizer's tsunami relief efforts.
You may also be interested in...
Pfizer CEO Plugs HIV Pipeline Agent At Presidential Advisory Council Meeting
The CCR5 inhibitor could be on the market "in a couple of years," CEO McKinnell says. He praises industry efforts to develop fixed-dose HIV/AIDS combinations but acknowledges that such partnerships can be "four times as difficult" as a developing a standalone product.
Pfizer CEO Plugs HIV Pipeline Agent At Presidential Advisory Council Meeting
The CCR5 inhibitor could be on the market "in a couple of years," CEO McKinnell says. He praises industry efforts to develop fixed-dose HIV/AIDS combinations but acknowledges that such partnerships can be "four times as difficult" as a developing a standalone product.
Pfizer's Celebrex Showed Cardiovascular Risk In 1999 Alzheimer's Study
A study of celecoxib in Alzheimer's disease patients showed a statistically significant increase in cardiovascular events versus placebo. The study data are posted on PhRMA's clinicalstudyresults.org website, but Public Citizen alleges Pfizer recently revised the posting and questions when the data were submitted to FDA.